Several healthcare ETFs hold major pharmaceutical companies like Eli Lilly, J&J, and Novo Nordisk as top 3 positions, leading to competition for investor capital.

The entities involved

• Eli Lilly and Company →

  American pharmaceutical company

  • Lilly Canada sponsored an innovation challenge while HealthCareCAN highlighted access barriers in Canada.Tue 20:20
  • Houthis actions and Iran's geopolitical moves are elevating gas prices, prompting investors to rotate into safer, low-growth sectors.Mon 15:45
• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • Microsoft and Alphabet are funding the AI boom, while TRACE pricing data is used for bond comparisons and both companies hold AAA ratings.Tue 09:15
  • Gardiner Harris's investigative reporting led to fraud fines against Bristol-Myers Squibb and a book dissecting Johnson & Johnson scandals.Tue 01:35
• Novo Nordisk →

  Danish pharmaceutical company

  • Novo Nordisk's repurchase program is operating under the regulations of the European Union.Tue 16:52
  • Major pharmaceutical companies, including Viking Therapeutics, Eli Lilly, and Novo Nordisk, are advancing their weight loss drug pipelines.Mon 13:49

Related events

• Eli Lilly and Novo Nordisk are competing for market share in the weight loss drug sector.Jun 18
• Novo Nordisk and Astellas Pharma are noted as large-cap healthcare companies, with Novo Nordisk reporting higher revenue and earnings.Oct 23
• Eli Lilly and Company and Lockheed Martin are mentioned as active market players.Oct 14